ATG Brands and DSA

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 2014 Italy English Publisher:Elsevier BVJournal:American Journal of Transplantation, volume 14, page 737 (issn: 1600-6135,

Copyright policy )

Authors: Focosi D; BOGGI, UGO;

doi: 10.1111/ajt.12622

pmid: 24447779

handle: 11568/442477

ATG Brands and DSA

- Summary
- Subjects
- Metrics

Abstract

testing are under development (3,4). Fromthe clinical point of view, ATG treatment has been shownto lead to C4d deposition in the graft, and possibly toantibody-mediated graft damage in rare case reports (5,6).Knowing speciﬁcities in advance both makes shifting toanother brand possible and avoids unnecessary overtreat-ment because of a misdiagnosed antibody-mediatedrejection.From the data presented by Popow et al (1), anotherinteresting ﬁnding is the higher content of antibodiesagainst CD107a in ATG Fresenius

Country

Italy

Related Organizations

University of Pisa
Italy
Azienda Ospedaliera Universitaria Pisana
Italy

Keywords

T-Lymphocytes, Animals, Humans, Antilymphocyte Serum

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average